DNLI
Price
$14.41
Change
-$0.04 (-0.28%)
Updated
Jun 26, 10:38 AM (EDT)
Capitalization
2.1B
35 days until earnings call
GLSI
Price
$9.00
Change
-$0.05 (-0.55%)
Updated
Jun 25 closing price
Capitalization
120.31M
46 days until earnings call
Interact to see
Advertisement

DNLI vs GLSI

Header iconDNLI vs GLSI Comparison
Open Charts DNLI vs GLSIBanner chart's image
Denali Therapeutics
Price$14.41
Change-$0.04 (-0.28%)
Volume$200
Capitalization2.1B
Greenwich LifeSciences
Price$9.00
Change-$0.05 (-0.55%)
Volume$29.12K
Capitalization120.31M
DNLI vs GLSI Comparison Chart in %
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. GLSI commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and GLSI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (DNLI: $14.45 vs. GLSI: $9.00)
Brand notoriety: DNLI and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 79% vs. GLSI: 64%
Market capitalization -- DNLI: $2.1B vs. GLSI: $120.31M
DNLI [@Biotechnology] is valued at $2.1B. GLSI’s [@Biotechnology] market capitalization is $120.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, DNLI is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 3 TA indicator(s) are bullish while GLSI’s TA Score has 3 bullish TA indicator(s).

  • DNLI’s TA Score: 3 bullish, 6 bearish.
  • GLSI’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than GLSI.

Price Growth

DNLI (@Biotechnology) experienced а +2.56% price change this week, while GLSI (@Biotechnology) price change was +0.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +31.82%, and the average quarterly price growth was +15.37%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

GLSI is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.1B) has a higher market cap than GLSI($120M). GLSI YTD gains are higher at: -19.858 vs. DNLI (-29.097). GLSI has higher annual earnings (EBITDA): -16.75M vs. DNLI (-505.16M). DNLI has more cash in the bank: 818M vs. GLSI (2.75M). DNLI (0) and GLSI (0) have equivalent revenues.
DNLIGLSIDNLI / GLSI
Capitalization2.1B120M1,749%
EBITDA-505.16M-16.75M3,015%
Gain YTD-29.097-19.858147%
P/E RatioN/AN/A-
Revenue00-
Total Cash818M2.75M29,745%
Total Debt48.6MN/A-
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIGLSI
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 21 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIINX51.70N/A
N/A
Harbor International Investor
VEXAX145.00N/A
N/A
Vanguard Extended Market Index Admiral
PSMJX10.47N/A
N/A
Principal SmallCap Value II J
AVDNX13.97N/A
N/A
Avantis® International Equity G
PHLOX9.92-0.23
-2.27%
Philotimo Focused Growth and Income

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-0.55%
ABOS - GLSI
45%
Loosely correlated
-2.38%
DNLI - GLSI
43%
Loosely correlated
+0.35%
XBIT - GLSI
42%
Loosely correlated
-0.37%
CLDX - GLSI
42%
Loosely correlated
-0.88%
BEAM - GLSI
41%
Loosely correlated
-2.27%
More